Year: 2016
Language: English
Author(s): World Federation of Hemophilia
New panel discussion: Expanding Access to Hemophilia Treatment Products, what will be the game changer?
While the WFH vision is “Treatment for All,” the majority of the world’s population has little to no access to hemophilia care. Patient advocates and WFH Humanitarian Aid and Public Policy representatives debate what might be the game changer in improving access to clotting factor products beyond its current limitations.
Panel: Brian O’Mahony, Mark Brooker, Assad Haffar, Albert Farrugia, chaired by David Page.
The WFH Shared Decision Making (SDM) Tool is an interactive decision-support system designed to facilitate discussions regarding treatment options between
This fact sheet contains commonly asked questions and more information on gene therapy for hemophilia B. Learn more about different
This video gives a quick introduction to hemostatic rebalancing therapy. Learn more about different treatment options for hemophilia with the
This video gives a quick introduction to gene therapy for hemophilia. Learn more about different treatment options for hemophilia with
This fact sheet contains commonly asked questions and more information on gene therapy for hemophilia A. Learn more about different
This fact sheet contains commonly asked questions and more information on hemostatic rebalancing therapy. Learn more about different treatment options
